|
1
|
Muneoka K and Dawson LA: Evolution of
epimorphosis in mammals. J Exp Zool B Mol Dev Evol. 336:165–179.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cai S, Fu X and Sheng Z:
Dedifferentiation: A new approach in stem cell research.
Bioscience. 57:655–662. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang C, Liu W, Shen Y, Chen J, Zhu H, Yang
X, Jiang X, Wang Y and Zhou J: Cardiomyocyte dedifferentiation and
remodeling in 3D scaffolds to generate the cellular diversity of
engineering cardiac tissues. Biomater Sci. 7:4636–4650.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Becker RO: Induced dedifferentiation: A
possible alternative to embryonic stem cell transplants.
NeuroRehabilitation. 17:23–31. 2002.PubMed/NCBI
|
|
5
|
Yao Y and Wang C: Dedifferentiation:
Inspiration for devising engineering strategies for regenerative
medicine. NPJ Regen Med. 5(14)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sugawara A and Sato S: Application of
dedifferentiated fat cells for periodontal tissue regeneration. Hum
Cell. 27:12–21. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Biehl JK and Russell B: Introduction to
stem cell therapy. J Cardiovasc Nurs. 24:98–105. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jiang M, He B, Zhang Q, Ge H, Zang MH, Han
ZH, Liu JP, Li JH, Zhang Q, Li HB, et al: Randomized controlled
trials on the therapeutic effects of adult progenitor cells for
myocardial infarction: Meta-analysis. Expert Opin Biol Ther.
10:667–680. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sobhani A, Khanlarkhani N, Baazm M,
Mohammadzadeh F, Najafi A, Mehdinejadiani S and Sargolzaei Aval F:
Multipotent stem cell and current application. Acta Med Iran.
55:6–23. 2017.PubMed/NCBI
|
|
10
|
Feyen DAM, Gaetani R, Doevendans PA and
Sluijter JPG: Stem cell-based therapy: Improving myocardial cell
delivery. Adv Drug Deliv Rev. 106:104–115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sanchez-Gurmaches J and Guertin DA:
Adipocyte lineages: Tracing back the origins of fat. Biochim
Biophys Acta. 1842:340–351. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sebo ZL, Jeffery E, Holtrup B and
Rodeheffer MS: A mesodermal fate map for adipose tissue.
Development. 145(dev166801)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chamberlain G, Fox J, Ashton B and
Middleton J: Concise review: Mesenchymal stem cells: Their
phenotype, differentiation capacity, immunological features, and
potential for homing. Stem Cells. 25:2739–2749. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hepler C, Shan B, Zhang Q, Henry GH, Shao
M, Vishvanath L, Ghaben AL, Mobley AB, Strand D, Hon GC and Gupta
RK: Identification of functionally distinct fibro-inflammatory and
adipogenic stromal subpopulations in visceral adipose tissue of
adult mice. Elife. 7(e39636)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lynes MD and Tseng YH: Deciphering adipose
tissue heterogeneity. Ann N Y Acad Sci. 1411:5–20. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ronconi V, Turchi F, Bujalska IJ,
Giacchetti G and Boscaro M: Adipose cell-adrenal interactions:
Current knowledge and future perspectives. Trends Endocrinol Metab.
19:100–103. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mullur R, Liu YY and Brent GA: Thyroid
hormone regulation of metabolism. Physiol Rev. 94:355–382.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rippa AL, Kalabusheva EP and Vorotelyak
EA: Regeneration of dermis: Scarring and cells involved. Cells.
8(607)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Grant RW and Dixit VD: Adipose tissue as
an immunological organ. Obesity (Silver Spring). 23:512–518.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kassem M: Mesenchymal stem cells:
Biological characteristics and potential clinical applications.
Cloning Stem Cells. 6:369–374. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vojtaššák J, Danišovič Ľ, Kubeš M, Bakoš
D, Jarabek L, Uličná M and Blaško M: Autologous biograft and
mesenchymal stem cells in treatment of the diabetic foot.
Neuroendocrinol Lett. 27 (Suppl 2):S134–S137. 2006.PubMed/NCBI
|
|
22
|
Smith RKW: Mesenchymal stem cell therapy
for equine tendinopathy. Disabil Rehabil. 30:1752–1758.
2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhou W, Han C, Song Y, Yan X, Li D, Chai
Z, Feng Z, Dong Y, Li L, Xie X, et al: The performance of bone
marrow mesenchymal stem cell-implant complexes prepared by cell
sheet engineering techniques. Biomaterials. 31:3212–3221.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pountos I, Jones E, Tzioupis C, McGonagle
D and Giannoudis PV: Growing bone and cartilage. The role of
mesenchymal stem cells. J Bone Joint Surg Br. 88:421–426.
2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Holmes B, Fang X, Zarate A, Keidar M and
Zhang LG: Enhanced human bone marrow mesenchymal stem cell
chondrogenic differentiation in electrospun constructs with carbon
nanomaterials. Carbon. 97:1–13. 2016.
|
|
26
|
Gianakos AL, Sun L, Patel JN, Adams DM and
Liporace FA: Clinical application of concentrated bone marrow
aspirate in orthopaedics: A systematic review. World J Orthop.
8:491–506. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sakamoto T, Miyazaki T, Watanabe S,
Takahashi A, Honjoh K, Nakajima H, Oki H, Kokubo Y and Matsumine A:
Intraarticular injection of processed lipoaspirate cells has
anti-inflammatory and analgesic effects but does not improve
degenerative changes in murine monoiodoacetate-induced
osteoarthritis. BMC Musculoskelet Disord. 20(335)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Roubelakis MG, Pappa KI, Bitsika V,
Zagoura D, Vlahou A, Papadaki HA, Antsaklis A and Anagnou NP:
Molecular and proteomic characterization of human mesenchymal stem
cells derived from amniotic fluid: Comparison to bone marrow
mesenchymal stem cells. Stem Cells Dev. 16:931–952. 2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bieback K, Kern S, Kocaömer A, Ferlik K
and Bugert P: Comparing mesenchymal stromal cells from different
human tissues: Bone marrow, adipose tissue and umbilical cord
blood. Biomed Mater Eng. 18 (1 Suppl):S71–S76. 2008.PubMed/NCBI
|
|
30
|
Francis MP, Sachs PC, Elmore LW and Holt
SE: Isolating adipose-derived mesenchymal stem cells from
lipoaspirate blood and saline fraction. Organogenesis. 6:11–14.
2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wouters G, Grossi S, Mesoraca A, Bizzoco
D, Mobili L, Cignini P and Giorlandino C: Isolation of amniotic
fluid-derived mesenchymal stem cells. J Prenat Med. 1:39–40.
2007.PubMed/NCBI
|
|
32
|
Li C, Kilpatrick CD, Smith S, Glettig DL,
Glod DJ, Mallette J, Strunk MR, Chang J, Angle SR and Kaplan DL:
Assessment of multipotent mesenchymal stromal cells in bone marrow
aspirate from human calcaneus. J Foot Ankle Surg. 56:42–46.
2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Matsumoto T, Kano K, Kondo D, Fukuda N,
Iribe Y, Tanaka N, Matsubara Y, Sakuma T, Satomi A, Otaki M, et al:
Mature adipocyte-derived dedifferentiated fat cells exhibit
multilineage potential. J Cell Physiol. 215:210–222.
2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Turner NJ, Jones HS, Davies JE and
Canfield AE: Cyclic stretch-induced TGFbeta1/Smad signaling
inhibits adipogenesis in umbilical cord progenitor cells. Biochem
Biophys Res Commun. 377:1147–1151. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gustafson B and Smith U: Activation of
canonical wingless-type MMTV integration site family (Wnt)
signaling in mature adipocytes increases beta-catenin levels and
leads to cell dedifferentiation and insulin resistance. J Biol
Chem. 285:14031–14041. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Strioga M, Viswanathan S, Darinskas A,
Slaby O and Michalek J: Same or not the same? Comparison of adipose
tissue-derived versus bone marrow-derived mesenchymal stem and
stromal cells. Stem Cells Dev. 21:2724–2752. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liao Y, Zeng Z, Lu F, Dong Z, Chang Q and
Gao J: In vivo dedifferentiation of adult adipose cells. PLoS One.
10(e0125254)2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tzameli I, Fang H, Ollero M, Shi H, Hamm
JK, Kievit P, Hollenberg AN and Flier JS: Regulated production of a
peroxisome proliferator-activated receptor-gamma ligand during an
early phase of adipocyte differentiation in 3T3-L1 adipocytes. J
Biol Chem. 279:36093–36102. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhuang H, Zhang X, Zhu C, Tang X, Yu F,
Shang GW and Cai X: Molecular mechanisms of PPAR-γ governing MSC
osteogenic and adipogenic differentiation. Curr Stem Cell Res Ther.
11:255–264. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wieser F, Waite L, Depoix C and Taylor RN:
PPAR action in human placental development and pregnancy and its
complications. PPAR Res. 2008(527048)2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yessoufou A and Wahli W: Multifaceted
roles of peroxisome proliferator-activated receptors (PPARs) at the
cellular and whole organism levels. Swiss Med Wkly.
140(w13071)2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Takada I, Kouzmenko AP and Kato S: Wnt and
PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev
Rheumatol. 5:442–447. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Otto TC and Lane MD: Adipose development:
From stem cell to adipocyte. Crit Rev Biochem Mol Biol. 40:229–242.
2005.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen L, Song J, Cui J, Hou J, Zheng X, Li
C and Liu L: microRNAs regulate adipocyte differentiation. Cell
Biol Int. 37:533–546. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
McBeath R, Pirone DM, Nelson CM,
Bhadriraju K and Chen CS: Cell shape, cytoskeletal tension, and
RhoA regulate stem cell lineage commitment. Dev Cell. 6:483–495.
2004.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Clabaut A, Delplace S, Chauveau C,
Hardouin P and Broux O: Human osteoblasts derived from mesenchymal
stem cells express adipogenic markers upon coculture with bone
marrow adipocytes. Differentiation. 80:40–45. 2010.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Wang QA, Song A, Chen W, Schwalie PC,
Zhang F, Vishvanath L, Jiang L, Ye R, Shao M, Tao C, et al:
Reversible De-differentiation of mature white adipocytes into
preadipocyte-like precursors during lactation. Cell Metab.
28:282–288.e3. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kruglikov IL, Zhang Z and Scherer PE: The
role of immature and mature adipocytes in hair cycling. Trends
Endocrinol Metab. 30:93–105. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Maurizi G, Della Guardia L, Maurizi A and
Poloni A: Adipocytes properties and crosstalk with immune system in
obesity-related inflammation. J Cell Physiol. 233:88–97.
2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Marangoni RG, Korman BD, Wei J, Wood TA,
Graham LV, Whitfield ML, Scherer PE, Tourtellotte WG and Varga J:
Myofibroblasts in murine cutaneous fibrosis originate from
adiponectin-positive intradermal progenitors. Arthritis Rheumatol.
67:1062–1073. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Motrescu ER and Rio MC: Cancer cells,
adipocytes and matrix metalloproteinase 11: A vicious tumor
progression cycle. Biol Chem. 389:1037–1041. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Plikus MV, Guerrero-Juarez CF, Ito M, Li
YR, Dedhia PH, Zheng Y, Shao M, Gay DL, Ramos R, His TC, et al:
Regeneration of fat cells from myofibroblasts during wound healing.
Science. 355:748–752. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Merrick D and Seale P: Skinny fat cells
stimulate wound healing. Cell Stem Cell. 26:801–803.
2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kurebayashi S, Sumitani S, Kasayama S,
Jetten AM and Hirose T: TNF-alpha inhibits 3T3-L1 adipocyte
differentiation without downregulating the expression of C/EBPbeta
and delta. Endocr J. 48:249–253. 2001.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sartipy P and Loskutoff DJ: Monocyte
chemoattractant protein 1 in obesity and insulin resistance. Proc
Natl Acad Sci USA. 100:7265–7270. 2003.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ruan H and Lodish HF: Insulin resistance
in adipose tissue: Direct and indirect effects of tumor necrosis
factor-alpha. Cytokine Growth Factor Rev. 14:447–455.
2003.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Kanda H, Tateya S, Tamori Y, Kotani K,
Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K and
Kasuga M: MCP-1 contributes to macrophage infiltration into adipose
tissue, insulin resistance, and hepatic steatosis in obesity. J
Clin Invest. 116:1494–1505. 2006.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Panee J: Monocyte chemoattractant protein
1 (MCP-1) in obesity and diabetes. Cytokine. 60:1–12.
2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Furlan F, Orlando S, Laudanna C, Resnati
M, Basso V, Blasi F and Mondino A: The soluble D2D3(88-274)
fragment of the urokinase receptor inhibits monocyte chemotaxis and
integrin-dependent cell adhesion. J Cell Sci. 117:2909–2916.
2004.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Montuori N and Ragno P: Multiple
activities of a multifaceted receptor: Roles of cleaved and soluble
uPAR. Front Biosci (Landmark Ed). 14:2494–2503. 2009.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Catalán V, Frühbeck G and Gómez-Ambrosi J:
Chapter 8-Inflammatory and oxidative stress markers in skeletal
muscle of obese subjects. In: Obesity. del Moral AM and Aguilera
García CM (eds). Academic Press, pp163-189, 2018.
|
|
62
|
Yang D, Wei F, Tewary P, Howard OM and
Oppenheim JJ: Alarmin-induced cell migration. Eur J Immunol.
43:1412–1418. 2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Ren P, Sun D, Xin D, Ma W, Chen P, Gao H,
Zhang S and Gong M: Serum amyloid A promotes osteosarcoma invasion
via upregulating αvβ3 integrin. Mol Med Rep. 10:3106–3112.
2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Bernstein AM, Twining SS, Warejcka DJ,
Tall E and Masur SK: Urokinase receptor cleavage: A crucial step in
fibroblast-to-myofibroblast differentiation. Mol Biol Cell.
18:2716–2727. 2007.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Resnati M, Pallavicini I, Wang JM,
Oppenheim J, Serhan CN, Romano M and Blasi F: The fibrinolytic
receptor for urokinase activates the G protein-coupled chemotactic
receptor FPRL1/LXA4R. Proc Natl Acad Sci USA. 99:1359–1364.
2002.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu D, Kou X, Chen C, Liu S, Liu Y, Yu W,
Yu T, Yang R, Wang R, Zhou Y and Shi S: Circulating apoptotic
bodies maintain mesenchymal stem cell homeostasis and ameliorate
osteopenia via transferring multiple cellular factors. Cell Res.
28:918–933. 2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
He W, Tan R, Dai C, Li Y, Wang D, Hao S,
Kahn M and Liu Y: Plasminogen activator inhibitor-1 is a
transcriptional target of the canonical pathway of Wnt/beta-catenin
signaling. J Biol Chem. 285:24665–24675. 2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Akimoto T, Ushida T, Miyaki S, Akaogi H,
Tsuchiya K, Yan Z, Williams RS and Tateishi T: Mechanical stretch
inhibits myoblast-to-adipocyte differentiation through Wnt
signaling. Biochem Biophys Res Commun. 329:381–385. 2005.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lee H, Kang R, Bae S and Yoon Y: AICAR, an
activator of AMPK, inhibits adipogenesis via the WNT/β-catenin
pathway in 3T3-L1 adipocytes. Int J Mol Med. 28:65–71.
2011.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Renner G, Noulet F, Mercier MC, Choulier
L, Etienne-Selloum N, Gies JP, Lehmann M, Lelong-Rebel I, Martin S
and Dontenwill M: Expression/activation of α5β1 integrin is linked
to the β-catenin signaling pathway to drive migration in glioma
cells. Oncotarget. 7:62194–62207. 2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Liang X, Kanjanabuch T, Mao SL, Hao CM,
Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB and Ma LJ:
Plasminogen activator inhibitor-1 modulates adipocyte
differentiation. Am J Physiol Endocrinol Metab. 290:E103–E113.
2006.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Swiatkowska M, Szemraj J and Cierniewski
CS: Induction of PAI-1 expression by tumor necrosis factor alpha in
endothelial cells is mediated by its responsive element located in
the 4G/5G site. FEBS J. 272:5821–5831. 2005.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Kruithof EK: Regulation of plasminogen
activator inhibitor type 1 gene expression by inflammatory
mediators and statins. Thromb Haemost. 100:969–975. 2008.PubMed/NCBI
|
|
74
|
Su SC, Lin CW, Yang WE, Fan WL and Yang
SF: The urokinase-type plasminogen activator (uPA) system as a
biomarker and therapeutic target in human malignancies. Expert Opin
Ther Targets. 20:551–566. 2016.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Prabhakar NR and Semenza GL: Oxygen
sensing and homeostasis. Physiology (Bethesda). 30:340–348.
2015.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Darby IA and Hewitson TD: Hypoxia in
tissue repair and fibrosis. Cell Tissue Res. 365:553–562.
2016.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Fierro FA, O'Neal AJ, Beegle JR, Chávez
MN, Peavy TR, Isseroff RR and Egaña JT: Hypoxic pre-conditioning
increases the infiltration of endothelial cells into scaffolds for
dermal regeneration pre-seeded with mesenchymal stem cells. Front
Cell Dev Biol. 3(68)2015.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Ye J: Adipose tissue vascularization: Its
role in chronic inflammation. Curr Diab Rep. 11:203–210.
2011.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Lund IK, Nielsen BS, Almholt K, Rønø B,
Hald A, Illemann M, Green KA, Christensen IJ, Rømer J and Lund LR:
Concomitant lack of MMP9 and uPA disturbs physiological tissue
remodeling. Dev Biol. 358:56–67. 2011.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Carriero MV and Stoppelli MP: The
urokinase-type plasminogen activator and the generation of
inhibitors of urokinase activity and signaling. Curr Pharm Des.
17:1944–1961. 2011.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010.PubMed/NCBI View Article : Google Scholar
|
|
82
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: Multifunctional contributors to tumor
progression. Mol Med Today. 6:149–156. 2000.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zhao Y, Lyons CE Jr, Xiao A, Templeton DJ,
Sang QA, Brew K and Hussaini IM: Urokinase directly activates
matrix metalloproteinases-9: A potential role in glioblastoma
invasion. Biochem Biophys Res Commun. 369:1215–1220.
2008.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Lafont JE: Lack of oxygen in articular
cartilage: Consequences for chondrocyte biology. Int J Exp Pathol.
91:99–106. 2010.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Shen J, Sugawara A, Yamashita J, Ogura H
and Sato S: Dedifferentiated fat cells: An alternative source of
adult multipotent cells from the adipose tissues. Int J Oral Sci.
3:117–124. 2011.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Hausman GJ and Richardson RL: Adipose
tissue angiogenesis. J Anim Sci. 82:925–934. 2004.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Lijnen HR: Angiogenesis and obesity.
Cardiovasc Res. 78:286–293. 2008.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Trayhurn P: Hypoxia and adipose tissue
function and dysfunction in obesity. Physiol Rev. 93:1–21.
2013.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Chabot V, Dromard C, Rico A, Langonné A,
Gaillard J, Guilloton F, Casteilla L and Sensebé L: Urokinase-type
plasminogen activator receptor interaction with β1 integrin is
required for platelet-derived growth factor-AB-induced human
mesenchymal stem/stromal cell migration. Stem Cell Res Ther.
6(188)2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Crandall DL, Busler DE, McHendry-Rinde B,
Groeling TM and Kral JG: Autocrine regulation of human preadipocyte
migration by plasminogen activator inhibitor-1. J Clin Endocrinol
Metab. 85:2609–2614. 2000.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Egners A, Erdem M and Cramer T: The
response of macrophages and neutrophils to hypoxia in the context
of cancer and other inflammatory diseases. Mediators Inflamm.
2016(2053646)2016.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Salasznyk RM, Zappala M, Zheng M, Yu L,
Wilkins-Port C and McKeown-Longo PJ: The uPA receptor and the
somatomedin B region of vitronectin direct the localization of uPA
to focal adhesions in microvessel endothelial cells. Matrix Biol.
26:359–370. 2007.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Xue Y, Petrovic N, Cao R, Larsson O, Lim
S, Chen S, Feldmann HM, Liang Z, Zhu Z, Nedergaard J, et al:
Hypoxia-independent angiogenesis in adipose tissues during cold
acclimation. Cell Metab. 9:99–109. 2009.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Jośko J and Mazurek M: Transcription
factors having impact on vascular endothelial growth factor (VEGF)
gene expression in angiogenesis. Med Sci Monit. 10:RA89–RA98.
2004.PubMed/NCBI
|
|
95
|
Weis SM and Cheresh DA: Pathophysiological
consequences of VEGF-induced vascular permeability. Nature.
437:497–504. 2005.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Vandoorne K, Addadi Y and Neeman M:
Visualizing vascular permeability and lymphatic drainage using
labeled serum albumin. Angiogenesis. 13:75–85. 2010.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Kobayashi J, Yamada S and Kawasaki H:
Distribution of vitronectin in plasma and liver tissue:
Relationship to chronic liver disease. Hepatology. 20:1412–1417.
1994.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Goerges AL and Nugent MA: pH regulates
vascular endothelial growth factor binding to fibronectin: A
mechanism for control of extracellular matrix storage and release.
J Biol Chem. 279:2307–2315. 2004.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Hapke S, Kessler H, Arroyo de Prada N,
Benge A, Schmitt M, Lengyel E and Reuning U: Integrin
alpha(v)beta(3)/vitronectin interaction affects expression of the
urokinase system in human ovarian cancer cells. J Biol Chem.
276:26340–26348. 2001.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Chu Y, Bucci JC and Peterson CB:
Identification of a PAI-1-binding site within an intrinsically
disordered region of vitronectin. Protein Sci. 29:494–508.
2020.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Arroyo De Prada N, Schroeck F, Sinner EK,
Muehlenweg B, Twellmeyer J, Sperl S, Wilhelm OG, Schmitt M and
Magdolen V: Interaction of plasminogen activator inhibitor type-1
(PAI-1) with vitronectin. Eur J Biochem. 269:184–192.
2002.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Wang L, Ly CM, Ko CY, Meyers EE, Lawrence
DA and Bernstein AM: uPA binding to PAI-1 induces corneal
myofibroblast differentiation on vitronectin. Invest Ophthalmol Vis
Sci. 53:4765–4775. 2012.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Czekay RP, Aertgeerts K, Curriden SA and
Loskutoff DJ: Plasminogen activator inhibitor-1 detaches cells from
extracellular matrices by inactivating integrins. J Cell Biol.
160:781–791. 2003.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Mousa SA: Vitronectin receptors in
vascular disorders. Curr Opin Investig Drugs. 3:1191–1195.
2002.PubMed/NCBI
|
|
105
|
Seiffert D, Iruela-Arispe ML, Sage EH and
Loskutoff DJ: Distribution of vitronectin mRNA during murine
development. Dev Dyn. 203:71–79. 1995.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Aaboe M, Offersen BV, Christensen A and
Andreasen PA: Vitronectin in human breast carcinomas. Biochim
Biophys Acta. 1638:72–82. 2003.PubMed/NCBI View Article : Google Scholar
|
|
107
|
van Aken BE, Seiffert D, Thinnes T and
Loskutoff DJ: Localization of vitronectin in the normal and
atherosclerotic human vessel wall. Histochem Cell Biol.
107:313–320. 1997.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Shi F and Sottile J: Caveolin-1-dependent
beta1 integrin endocytosis is a critical regulator of fibronectin
turnover. J Cell Sci. 121:2360–2371. 2008.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Lenselink EA: Role of fibronectin in
normal wound healing. Int Wound J. 12:313–316. 2015.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Ricard-Blum S: The collagen family. Cold
Spring Harb Perspect Biol. 3(a004978)2011.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Scherer PE and Hill JA: Obesity, diabetes,
and cardiovascular diseases: A compendium. Circ Res. 118:1703–1705.
2016.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Zhang X, Zhang Y, Wang P, Zhang SY, Dong
Y, Zeng G, Yan Y, Sun L, Wu Q, Liu H, et al: Adipocyte
hypoxia-inducible factor 2α suppresses atherosclerosis by promoting
adipose ceramide catabolism. Cell Metab. 30:937–951.e5.
2019.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Kaneko M, Minematsu T, Yoshida M,
Nishijima Y, Noguchi H, Ohta Y, Nakagami G, Mori T and Sanada H:
Compression-induced HIF-1 enhances thrombosis and PAI-1 expression
in mouse skin. Wound Repair Regen. 23:657–663. 2015.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Samad F, Schneiderman J and Loskutoff D:
Expression of fibrinolytic genes in tissues from human
atherosclerotic aneurysms and from obese mice. Ann N Y Acad Sci.
811:350–360. 1997.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Qureshi R, Kindo M, Arora H, Boulberdaa M,
Steenman M and Nebigil CG: Prokineticin receptor-1-dependent
paracrine and autocrine pathways control cardiac tcf21+
fibroblast progenitor cell transformation into adipocytes and
vascular cells. Sci Rep. 7(12804)2017.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Li JQ, Zhao SP, Li QZ, Cai YC, Wu LR, Fang
Y and Li P: Atorvastatin reduces plasminogen activator inhibitor-1
expression in adipose tissue of atherosclerotic rabbits. Clin Chim
Acta. 370:57–62. 2006.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Geis T, Döring C, Popp R, Grossmann N,
Fleming I, Hansmann ML, Dehne N and Brüne B: HIF-2alpha-dependent
PAI-1 induction contributes to angiogenesis in hepatocellular
carcinoma. Exp Cell Res. 331:46–57. 2015.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Ekmekci H, Sonmez H, Ekmekci OB, Ozturk Z,
Domanic N and Kokoglu E: Plasma vitronectin levels in patients with
coronary atherosclerosis are increased and correlate with extent of
disease. J Thromb Thrombolysis. 14:221–225. 2002.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Reuning U, Magdolen V, Hapke S and Schmitt
M: Molecular and functional interdependence of the urokinase-type
plasminogen activator system with integrins. Biol Chem.
384:1119–1131. 2003.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Chiellini C, Cochet O, Negroni L, Samson
M, Poggi M, Ailhaud G, Alessi MC, Dani C and Amri EZ:
Characterization of human mesenchymal stem cell secretome at early
steps of adipocyte and osteoblast differentiation. BMC Mol Biol.
9(26)2008.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Ekström M, Liska J, Eriksson P,
Sverremark-Ekström E and Tornvall P: Stimulated in vivo synthesis
of plasminogen activator inhibitor-1 in human adipose tissue.
Thromb Haemost. 108:485–492. 2012.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Lijnen HR, Maquoi E, Demeulemeester D, Van
Hoef B and Collen D: Modulation of fibrinolytic and gelatinolytic
activity during adipose tissue development in a mouse model of
nutritionally induced obesity. Thromb Haemost. 88:345–353.
2002.PubMed/NCBI
|
|
123
|
Efimenko A, Starostina E, Kalinina N and
Stolzing A: Angiogenic properties of aged adipose derived
mesenchymal stem cells after hypoxic conditioning. J Transl Med.
9(10)2011.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Zhou A, Huntington JA, Pannu NS, Carrell
RW and Read RJ: How vitronectin binds PAI-1 to modulate
fibrinolysis and cell migration. Nat Struct Biol. 10:541–544.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
125
|
Fukui N, Ikeda Y, Tanaka N, Wake M,
Yamaguchi T, Mitomi H, Ishida S, Furukawa H, Hamada Y, Miyamoto Y,
et al: αvβ5 Integrin promotes dedifferentiation of
monolayer-cultured articular chondrocytes. Arthritis Rheum.
63:1938–1949. 2011.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Goessler UR, Bieback K, Bugert P, Heller
T, Sadick H, Hörmann K and Riedel F: In vitro analysis of
integrin expression during chondrogenic differentiation of
mesenchymal stem cells and chondrocytes upon dedifferentiation in
cell culture. Int J Mol Med. 17:301–307. 2006.PubMed/NCBI
|
|
127
|
Clemmons DR, Maile LA, Ling Y, Yarber J
and Busby WH: Role of the integrin alphaVbeta3 in mediating
increased smooth muscle cell responsiveness to IGF-I in response to
hyperglycemic stress. Growth Horm IGF Res. 17:265–270.
2007.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Czekay RP, Kuemmel TA, Orlando RA and
Farquhar MG: Direct binding of occupied urokinase receptor (uPAR)
to LDL receptor-related protein is required for endocytosis of uPAR
and regulation of cell surface urokinase activity. Mol Biol Cell.
12:1467–1479. 2001.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Binder BR, Mihaly J and Prager GW:
uPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's
view. Thromb Haemost. 97:336–342. 2007.PubMed/NCBI
|
|
130
|
Cortese K, Sahores M, Madsen CD, Tacchetti
C and Blasi F: Clathrin and LRP-1-independent constitutive
endocytosis and recycling of uPAR. PLoS One.
3(e3730)2008.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Rabiej VK, Pflanzner T, Wagner T, Goetze
K, Storck SE, Eble JA, Weggen S, Mueller-Klieser W and Pietrzik CU:
Low density lipoprotein receptor-related protein 1 mediated
endocytosis of β1-integrin influences cell adhesion and cell
migration. Exp Cell Res. 340:102–115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Crampton SP, Wu B, Park EJ, Kim JH,
Solomon C, Waterman ML and Hughes CC: Integration of the
beta-catenin-dependent Wnt pathway with integrin signaling through
the adaptor molecule Grb2. PLoS One. 4(e7841)2009.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Dejaeger M, Böhm AM, Dirckx N, Devriese J,
Nefyodova E, Cardoen R, St-Arnaud R, Tournoy J, Luyten FP and Maes
C: Integrin-linked kinase regulates bone formation by controlling
cytoskeletal organization and modulating BMP and Wnt signaling in
osteoprogenitors. J Bone Miner Res. 32:2087–2102. 2017.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Zucker MM, Wujak L, Gungl A, Didiasova M,
Kosanovic D, Petrovic A, Klepetko W, Schermuly RT, Kwapiszewska G,
Schaefer L and Wygrecka M: LRP1 promotes synthetic phenotype of
pulmonary artery smooth muscle cells in pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 1865:1604–1616. 2019.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Koraishy FM, Silva C, Mason S, Wu D and
Cantley LG: Hepatocyte growth factor (Hgf) stimulates low density
lipoprotein receptor-related protein (Lrp) 5/6 phosphorylation and
promotes canonical Wnt signaling. J Biol Chem. 289:14341–14350.
2014.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Masson O, Chavey C, Dray C, Meulle A,
Daviaud D, Quilliot D, Muller C, Valet P and Liaudet-Coopman E:
LRP1 receptor controls adipogenesis and is up-regulated in human
and mouse obese adipose tissue. PLoS One. 4(e7422)2009.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Jiang F, Parsons CJ and Stefanovic B: Gene
expression profile of quiescent and activated rat hepatic stellate
cells implicates Wnt signaling pathway in activation. J Hepatol.
45:401–409. 2006.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Ding X, Tong Y, Jin S, Chen Z, Li T,
Billiar TR, Pitt BR, Li Q and Zhang LM: Mechanical ventilation
enhances extrapulmonary sepsis-induced lung injury: Role of
WISP1-αvβ5 integrin pathway in TLR4-mediated inflammation and
injury. Crit Care. 22(302)2018.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Stephens S, Palmer J, Konstantinova I,
Pearce A, Jarai G and Day E: A functional analysis of Wnt inducible
signalling pathway protein-1 (WISP-1/CCN4). J Cell Commun Signal.
9:63–72. 2015.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Ono M, Inkson CA, Kilts TM and Young MF:
WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J
Bone Miner Res. 26:193–208. 2011.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Xu J and Liao K: Protein kinase B/AKT 1
plays a pivotal role in insulin-like growth factor-1 receptor
signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem.
279:35914–35922. 2004.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Gondi CS, Kandhukuri N, Dinh DH, Gujrati M
and Rao JS: Down-regulation of uPAR and uPA activates
caspase-mediated apoptosis and inhibits the PI3K/AKT pathway. Int J
Oncol. 31:19–27. 2007.PubMed/NCBI
|
|
143
|
Whitley BR, Beaulieu LM, Carter JC and
Church FC: Phosphatidylinositol 3-kinase/Akt regulates the balance
between plasminogen activator inhibitor-1 and urokinase to promote
migration of SKOV-3 ovarian cancer cells. Gynecol Oncol.
104:470–479. 2007.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Karbiener M, Neuhold C, Opriessnig P,
Prokesch A, Bogner-Strauss JG and Scheideler M: MicroRNA-30c
promotes human adipocyte differentiation and co-represses PAI-1 and
ALK2. RNA Biol. 8:850–860. 2011.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg
RJ and Li X: miR-17-92 cluster accelerates adipocyte
differentiation by negatively regulating tumor-suppressor Rb2/p130.
Proc Natl Acad Sci USA. 105:2889–2894. 2008.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Karbiener M, Fischer C, Nowitsch S,
Opriessnig P, Papak C, Ailhaud G, Dani C, Amri EZ and Scheideler M:
microRNA miR-27b impairs human adipocyte differentiation and
targets PPARgamma. Biochem Biophys Res Commun. 390:247–251.
2009.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim
MM, Srikantan S, Martindale JL, Hutchison ER, Kim HH, Marasa BS, et
al: miR-130 suppresses adipogenesis by inhibiting peroxisome
proliferator-activated receptor gamma expression. Mol Cell Biol.
31:626–638. 2011.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Kim YJ, Hwang SJ, Bae YC and Jung JS:
MiR-21 regulates adipogenic differentiation through the modulation
of TGF-beta signaling in mesenchymal stem cells derived from human
adipose tissue. Stem Cells. 27:3093–3102. 2009.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Esau C, Kang X, Peralta E, Hanson E,
Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R, et
al: MicroRNA-143 regulates adipocyte differentiation. J Biol Chem.
279:52361–52365. 2004.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Hadadeh O, Barruet E, Peiretti F, Verdier
M, Bernot D, Hadjal Y, Yazidi CE, Robaglia-Schlupp A, De Paula AM,
Nègre D, et al: The plasminogen activation system modulates
differently adipogenesis and myogenesis of embryonic stem cells.
PLoS One. 7(e49065)2012.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Tang CH, Hill ML, Brumwell AN, Chapman HA
and Wei Y: Signaling through urokinase and urokinase receptor in
lung cancer cells requires interactions with beta1 integrins. J
Cell Sci. 121:3747–3756. 2008.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Baldwin LA, Hoff JT, Lefringhouse J, Zhang
M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, et al: CD151-α3β1
integrin complexes suppress ovarian tumor growth by repressing
slug-mediated EMT and canonical Wnt signaling. Oncotarget.
5:12203–12217. 2014.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Zhao G, Kim EW, Jiang J, Bhoot C, Charles
KR, Baek J, Mohan S, Adams JS, Tetradis S and Lyons KM: CCN1/Cyr61
is required in osteoblasts for responsiveness to the anabolic
activity of PTH. J Bone Miner Res. 35:2289–2300. 2020.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Asuthkar S, Gondi CS, Nalla AK, Velpula
KK, Gorantla B and Rao JS: Urokinase-type plasminogen activator
receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is
enhanced in irradiated medulloblastoma cells. J Biol Chem.
287:20576–20589. 2012.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Gondi CS, Kandhukuri N, Kondraganti S,
Gujrati M, Olivero WC, Dinh DH and Rao JS: Down-regulation of uPAR
and cathepsin B retards cofilin dephosphorylation. Int J Oncol.
28:633–639. 2006.PubMed/NCBI
|
|
156
|
Weisel JW: Fibrinogen and fibrin. In:
Advances in Protein Chemistry. Vol 70. Academic Press, Cambridge,
MA, pp247-299, 2005.
|
|
157
|
Neuss S, Schneider RK, Tietze L, Knüchel R
and Jahnen-Dechent W: Secretion of fibrinolytic enzymes facilitates
human mesenchymal stem cell invasion into fibrin clots. Cells
Tissues Organs. 191:36–46. 2010.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Valenick LV, Hsia HC and Schwarzbauer JE:
Fibronectin fragmentation promotes alpha4beta1 integrin-mediated
contraction of a fibrin-fibronectin provisional matrix. Exp Cell
Res. 309:48–55. 2005.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Gavin KM, Majka SM, Kohrt WM, Miller HL,
Sullivan TM and Klemm DJ: Hematopoietic-to-mesenchymal transition
of adipose tissue macrophages is regulated by integrin β1 and
fabricated fibrin matrices. Adipocyte. 6:234–249. 2017.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Rodríguez Fernández JL and Ben-Ze'ev A:
Regulation of fibronectin, integrin and cytoskeleton expression in
differentiating adipocytes: Inhibition by extracellular matrix and
polylysine. Differentiation. 42:65–74. 1989.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Liu LF, Shen WJ, Zhang ZH, Wang LJ and
Kraemer FB: Adipocytes decrease Runx2 expression in osteoblastic
cells: Roles of PPARγ and adiponectin. J Cell Physiol. 225:837–845.
2010.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Kortlever RM and Bernards R: Senescence,
wound healing and cancer: The PAI-1 connection. Cell Cycle.
5:2697–2703. 2006.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Zhang Y, Pan Y, Xie C and Zhang Y: miR-34a
exerts as a key regulator in the dedifferentiation of osteosarcoma
via PAI-1-Sox2 axis. Cell Death Dis. 9(777)2018.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Wang Z, Xing H, Hu H, Dai T, Wang Y, Li Z,
An R, Xu H, Liu Y and Liu B: Intraglandular transplantation of
adipose-derived stem cells combined with platelet-rich fibrin
extract for the treatment of irradiation-induced salivary gland
damage. Exp Ther Med. 15:795–805. 2018.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Gurewich V: Therapeutic fibrinolysis: How
efficacy and safety can be improved. J Am Coll Cardiol.
68:2099–2106. 2016.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Cao GQ, Li L, Wang YB, Shi ZZ, Fan DY and
Chen HY: Treatment of free-flowing tuberculous pleurisy with
intrapleural urokinase. Int J Tuberc Lung Dis. 19:1395–1400.
2015.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Berkenpas MB, Lawrence DA and Ginsburg D:
Molecular evolution of plasminogen activator inhibitor-1 functional
stability. EMBO J. 14:2969–2977. 1995.PubMed/NCBI
|
|
168
|
Naderi N, Griffin MF, Mosahebi A, Butler
PE and Seifalian AM: Adipose derived stem cells and platelet rich
plasma improve the tissue integration and angiogenesis of
biodegradable scaffolds for soft tissue regeneration. Mol Biol Rep.
47:2005–2013. 2020.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Rahman SU, Park CH, Baek JH, Ryoo HM and
Woo KM: Fibrin-enhanced canonical Wnt signaling directs plasminogen
expression in cementoblasts. Int J Mol Sci. 18(2380)2017.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Tara S and Krishnan LK: Differentiation of
circulating neural progenitor cells in vitro on fibrin-based
composite-matrix involves Wnt-β-catenin-like signaling. J Cell
Commun Signal. 13:27–38. 2019.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Zhou C, Li S, Wenqiguli N, Yu L, Zhao L,
Wu P and Nijiati T: The expressions of the Notch and Wnt signaling
pathways and their significance in the repair process of alveolar
bone defects in rabbits with bone marrow stem cells compounded with
platelet-rich fibrin. Hua Xi Kou Qiang Yi Xue Za Zhi. 34:130–135.
2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
